Medtronic EBITDA Margin 2010-2025 | MDT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Medtronic (MDT) over the last 10 years. The current EBITDA margin for Medtronic as of January 31, 2025 is .
| Medtronic EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2025-01-31 |
$33.20B |
$8.25B |
24.84% |
| 2024-10-31 |
$33.00B |
$8.05B |
24.40% |
| 2024-07-31 |
$32.58B |
$7.79B |
23.92% |
| 2024-04-30 |
$32.36B |
$7.79B |
24.08% |
| 2024-01-31 |
$32.32B |
$8.33B |
25.78% |
| 2023-10-31 |
$31.96B |
$8.27B |
25.88% |
| 2023-07-31 |
$31.56B |
$8.33B |
26.40% |
| 2023-04-30 |
$31.23B |
$8.18B |
26.20% |
| 2023-01-31 |
$30.77B |
$8.30B |
26.96% |
| 2022-10-31 |
$30.81B |
$8.56B |
27.78% |
| 2022-07-31 |
$31.07B |
$8.72B |
28.07% |
| 2022-04-30 |
$31.69B |
$8.46B |
26.70% |
| 2022-01-31 |
$31.79B |
$8.39B |
26.39% |
| 2021-10-31 |
$31.80B |
$8.01B |
25.20% |
| 2021-07-31 |
$31.60B |
$7.37B |
23.34% |
| 2021-04-30 |
$30.12B |
$7.19B |
23.86% |
| 2021-01-31 |
$27.93B |
$5.89B |
21.08% |
| 2020-10-31 |
$27.87B |
$6.23B |
22.37% |
| 2020-07-31 |
$27.93B |
$6.65B |
23.83% |
| 2020-04-30 |
$28.91B |
$7.45B |
25.78% |
| 2020-01-31 |
$31.06B |
$9.08B |
29.23% |
| 2019-10-31 |
$30.89B |
$8.99B |
29.12% |
| 2019-07-31 |
$30.67B |
$9.17B |
29.89% |
| 2019-04-30 |
$30.56B |
$8.93B |
29.21% |
| 2019-01-31 |
$30.56B |
$8.91B |
29.15% |
| 2018-10-31 |
$30.38B |
$8.79B |
28.94% |
| 2018-07-31 |
$29.95B |
$9.17B |
30.61% |
| 2018-04-30 |
$29.95B |
$9.28B |
31.00% |
| 2018-01-31 |
$29.73B |
$9.07B |
30.52% |
| 2017-10-31 |
$29.64B |
$8.86B |
29.88% |
| 2017-07-31 |
$29.93B |
$8.41B |
28.09% |
| 2017-04-30 |
$29.71B |
$8.30B |
27.94% |
| 2017-01-31 |
$29.36B |
$8.21B |
27.96% |
| 2016-10-31 |
$29.01B |
$8.40B |
28.96% |
| 2016-07-31 |
$28.73B |
$8.28B |
28.83% |
| 2016-04-30 |
$28.83B |
$8.21B |
28.47% |
| 2016-01-31 |
$28.57B |
$6.76B |
23.67% |
| 2015-10-31 |
$25.95B |
$6.24B |
24.03% |
| 2015-07-31 |
$23.26B |
$5.63B |
24.22% |
| 2015-04-30 |
$20.26B |
$5.15B |
25.41% |
| 2015-01-31 |
$17.52B |
$4.83B |
27.55% |
| 2014-10-31 |
$17.37B |
$4.52B |
26.01% |
| 2014-07-31 |
$17.20B |
$4.54B |
26.39% |
| 2014-04-30 |
$17.01B |
$4.67B |
27.47% |
| 2014-01-31 |
$16.90B |
$5.58B |
33.04% |
| 2013-10-31 |
$16.76B |
$5.80B |
34.59% |
| 2013-07-31 |
$16.67B |
$5.79B |
34.71% |
| 2013-04-30 |
$16.59B |
$5.68B |
34.23% |
| 2013-01-31 |
$16.43B |
$5.68B |
34.58% |
| 2012-10-31 |
$16.32B |
$5.61B |
34.37% |
| 2012-07-31 |
$16.25B |
$5.66B |
34.81% |
| 2012-04-30 |
$16.18B |
$5.67B |
35.01% |
| 2012-01-31 |
$15.86B |
$5.47B |
34.45% |
| 2011-10-31 |
$15.80B |
$5.46B |
34.57% |
| 2011-07-31 |
$15.68B |
$5.35B |
34.14% |
| 2011-04-30 |
$15.51B |
$5.27B |
34.00% |
| 2011-01-31 |
$15.30B |
$5.34B |
34.90% |
| 2010-10-31 |
$15.30B |
$5.46B |
35.71% |
| 2010-07-31 |
$15.23B |
$5.56B |
36.53% |
| 2010-04-30 |
$15.39B |
$5.65B |
36.73% |
| 2010-01-31 |
$15.45B |
$5.23B |
33.82% |
| 2009-10-31 |
$15.09B |
$4.91B |
32.54% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$108.824B |
$32.364B |
|
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.
|
